• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

If You Sold in May, Buy These Three


The "sell in May" part may be easy. But the then investors have to wonder, "and go where, exactly?"

This article was originally published by

With the S&P 500 down more than 6% since May 1, the old adage of "sell in May and go away" looks remarkably prescient once again.

With bond rates are continuing to rise in Spain and Italy despite a bailout agreement being reached, economic growth in China decelerating and a string of disappointing jobs data in the U.S., this could be another summer of poor stock market returns.

The "sell in May" part may be easy. But the then investors have to wonder, "and go where, exactly?"

The 10-year Treasury note yields just 1.6% —


below the rate of inflation. Savings and money market accounts are yielding even less. That means that you're earning a real return on your money.

That's no way to build wealth.

Not all stocks are down

Although most stocks have been negatively affected by the recent selloff, there are corners of the market that have held up remarkably well.

Listed below are three stocks that have performed very well during the recent pullback. And each one yields more than 3%, providing you with solid income to go along with that stability.

(SEP - Snapshot Report)

Spectra Energy Partners

Spectra Energy is a master limited partnership that owns and operates natural gas pipelines and storage assets in the United States. The partnership generates mostly fee-based income, so it is not particularly prone to fluctuations in natural gas prices.


This has allowed Spectra to raise its distribution 18 straight since going public back in 2007 (even during the Great Recession). It currently yields a solid 6.2%.

Shares have held up relatively well over the last several weeks. And with a beta of just 0.2, look for more stability going forward.

(NHI - Snapshot Report)

National Health Investors Inc.

A sovereign debt crisis in Europe has very little bearing on long-term health care facilities here in the United States. This must be why shares of NHI have been essentially flat since May 1 while the S&P has fallen more than -6%.

National Health Investors is a real estate investment trust that invests in health care properties primarily in the long-term care and senior housing industries. It has investments in 127 facilities in 24 states.

NHI also pays a dividend that yields 5.2%, which has provided support for the stock.

(KMB - Analyst Report)

Kimberly-Clark Corporation

Not only has this high quality, low-beta stock held up during the recent pullback, shares recently hit a new 52-week high as investors flee to quality.

The company delivered a solid earnings beat back in April and continues to generate solid, stable free cash flow. This has allowed it to pay a dividend that yields 3.6%. And over the last 10 years, it has increased it at a compound annual rate of 9%.

Kimberly-Clark does have exposure to Europe, and management warned that they "expect economic conditions to remain challenging" there. But the company's portfolio of consumer staples leaves it much less exposed to economic fluctuations than other companies.

The Bottom Line


Don't let the recent market volatility scare you away from stocks. These three have held up very well so far and looked poised to continue weathering the storm.

Todd Bunton is the Growth & Income Stock Strategist for Zacks Investment Research and Editor of the Income Plus Investor service.

This article originally appeared at Reprinted with permission. Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. Neither Zacks Investment Research, Inc., Physician's Money Digest, nor the information providers have any liability, contingent or otherwise, for the accuracy, completeness, timeliness, or correct sequencing of the information or for any decision made or action taken by you in reliance upon information or "," "," or "" or for interruption of any data, information or any other aspect of "," "," or "" The past performance of a mutual fund, stock or investment strategy cannot guarantee its future performance.

Related Videos
Victor J. Dzau, MD, gives expert advice
Victor J. Dzau, MD, gives expert advice